Frank H. Laukien - 18 Feb 2025 Form 4 Insider Report for BRUKER CORP (BRKR)

Signature
/s/ Frank H. Laukien
Issuer symbol
BRKR
Transactions as of
18 Feb 2025
Net transactions value
+$1,018,330
Form type
4
Filing time
19 Feb 2025, 16:23:26 UTC
Previous filing
19 Nov 2024
Next filing
09 Jun 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BRKR Common Stock Purchase $662,947 +13,063 +0.03% $50.75 38,452,626 18 Feb 2025 Direct F1
transaction BRKR Common Stock Purchase $355,383 +6,937 +0.02% $51.23 38,459,563 18 Feb 2025 Direct F2
holding BRKR Common Stock 1,046,499 18 Feb 2025 By Former Spouse
holding BRKR Common Stock 337,087 18 Feb 2025 By Son
holding BRKR Common Stock 336,607 18 Feb 2025 By Daughter
holding BRKR Common Stock 201,702 18 Feb 2025 As UTMA Custodian for Son
holding BRKR Common Stock 71,728 18 Feb 2025 As UTMA Custodian for Son
holding BRKR Common Stock 492 18 Feb 2025 By Former Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $50.10 to $51.09, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) of this Form 4.
F2 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $51.12 to $51.57, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (2) of this Form 4.